From April 1st, 2014, to March 31st, 2015, 67 intensive care units (ICUs) took part in surveillance of central line–associated bloodstream infections (CLABSIs), for a combined total of 130,776 catheter-days. Participating ICUs reported 115 CLABSIs in 112 patients. Incidence rates were 0.34 per 1,000 catheter-days in coronary ICUs, 0.52 in teaching adult ICUs, 0.76 in non-teaching adult ICUs, 2.06 in pediatric ICUs and 2.20 in neonatal ICUs. The incidence rates in 2014–2015 were lower compared to 2010–2014 in teaching adult as well as in neonatal ICUs while non-teaching adult, pediatric and coronary ICUs pooled mean rates remained stable. Compared to 2013-2014, two adult non-teaching ICUs with less than 10 beds and a neonatal ICU are not considered anymore in the results, having provided less than 11 periods of data. Data were extracted on May 20, 2015.

From April 1st, 2014, to March 31st, 2015, 88 healthcare facilities took part in the hospital-wide surveillance of bloodstream infections (BSIs), for a combined total of 4,733,772 patient-days. Participating facilities reported 3,035 BSIs in 2,832 patients. The total incidence rate was 5.3 cases per 10,000 patient-days. The incidence rate in 2014–2015 was significantly lower compared to the average rate for 2010–2014 in facilities that took part in both surveillance periods. Two teaching and 10 non-teaching facilities joined the program in 2014–2015 and one stopped participating; in addition, four facilities are not counted anymore in the 2013-2014 surveillance results, having provided data for less than 11 periods for this surveillance year. Data was extracted on May 20th, 2015.

Carbapenemases producer Gram negative bacilli infections
Surveillance results: 2014-2015

From April 1, 2014, to March 31, 2015, 67 healthcare facilities (participation rate: 75.2%) took part in the surveillance of carbapenemase-producing Gram negative bacilli (CPGNB) infections, for a total of 3,225,934 patient-days (Table 1).

In total, 9 CPGNB infections were reported among patients who acquired their strain during a current or previous hospital stay in the reporting…

From April 1, 2014, to March 31, 2015, 95 healthcare facilities participated in the surveillance of Clostridium difficile–associated diarrhea (CDAD), for a combined total of 5,076,655 inpatient days. The participating facilities reported 3,453 cases of healthcare-associated (HA) CDAD. The incidence rate of HA CDAD was 6.8 cases per 10,000 patient days. This incidence rate was significantly lower compared to the rate of 2013–2014. The 10-day fatality rate was 9.8% (n = 285) while the 30-day fatality rate was 18.6% (n = 543). In total, 36 (1.2%) colectomies were reported. Data was extracted on May 20th, 2015 and updated on June 1st 2015.  

From April 1, 2014, to March 31, 2015, 89 healthcare facilities took part in the surveillance of healthcare-associated vancomycin-resistant enterococci (VRE) infections, for a combined total of 4,839,578 patient days (Table 1). In total, 87 VRE infections were reported among patients who contracted strain during a current or previous hospital stay in the reporting facility (categories 1a + 1b). The incidence rate of healthcare-associated VRE infections (cat. 1a + 1b) was 0.18 / 10,000 patient days. This incidence rate was stable since 2013-2014. The acquisition rate of healthcare-associated VRE colonization (cat. 1a + 1b) was 10.99 / 10,000 patient days. Data was extracted on May 20th, 2015 and updated on June 1, 2015 for complications.

From April 1, 2013, to March 31, 2014, 89 healthcare facilities took part in the surveillance of healthcare-associated vancomycin-resistant enterococci (VRE) infections, for a combined total of 4,948,058 patient days (Table 1). In total, 92 VRE infections were reported among patients who contracted strain during a current or previous hospital stay in the reporting facility (categories 1a + 1b). The incidence rate of healthcare-associated VRE infections (cat. 1a + 1b) was 0.19 / 10,000 patient days. This incidence rate was two times higher than 2012-2013. The acquisition rate of healthcare-associated VRE colonization (cat. 1a + 1b) was 9.77 / 10,000 patient days. Data was extracted on May 15th, 2014.  

From April 1, 2013, to March 31, 2014, 95 healthcare facilities participated in the surveillance of Clostridium difficile–associated diarrhea (CDAD), for a combined total of 5,121,300 inpatient days. The participating facilities reported 3,661 cases of healthcare-associated (HA) CDAD. The incidence rate of HA CDAD was 7.1 cases per 10,000 patient days. This incidence rate was stable compared to the rate of 2012–2013. The 10-day fatality rate was 9.1% (n = 322) while the 30-day rate was 15.1% (n = 534). In total, 46 (1.3%) colectomies were reported. Data was extracted on May 15th, 2014.  

From April 1, 2014, to March 31, 2015, 88 healthcare facilities participated in the surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections, for a combined total of 4,689,050 inpatient days (Table 1). Together, these facilities reported 95 cases of healthcare-associated MRSA. The incidence rate was 0.20 / 10,000 patient-days. This incidence rate has declined over the past five years but has stabilized this year. The proportion of methicillin resistance in healthcare-associated S. aureus bloodstream infections was 17.8%. Data was extracted on May 20th, 2015 and updated on June 1st 2015 for complications

From April 1, 2013, to March 31, 2014, 88 healthcare facilities participated in the surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections, for a combined total of 4,939,160 inpatient days. Together, these facilities reported 97 cases of healthcare-associated MRSA. The incidence rate was 0.20 / 10,000 patient-days. This incidence rate has declined over the past five years. The proportion of methicillin resistance in healthcare-associated S. aureus bloodstream infections was 16.9%. Data was extracted from Si-SPIN on May 23th, 2014 and updated on June 3st 2014 for complications.

The Institut national de santé publique du Québec (INSPQ) [Québec’s public health institute] has been mandated by the Ministère de la Santé et des Services sociaux (MSSS) [Québec’s ministry of health and social services] to oversee the provincial surveillance of healthcare-associated (HA) infections. The Comité sur les infections nosocomiales du Québec (CINQ) [Québec healthcare-associated infections committee] and the Comité de surveillance provinciale des infections nosocomiales (SPIN) [Provincial committee for surveillance of healthcare-associated infections] have set up a structured…